DUBLIN, July 15, 2020 /PRNewswire/ -- Perrigo
Company plc (NYSE; TASE: PRGO), a leading provider of Quality,
Affordable Self-Care Products, today announced that it will
release its second quarter financial results on Wednesday, August 5, 2020. The Company will also
host a conference call beginning at 9:00
a.m. (EDT).
The conference call will be available live via webcast to
interested parties in the investor relations section of the Perrigo
website at http://perrigo.investorroom.com/events-webcasts or by
phone at 888-317-6003, International 412-317-6061, and reference ID
#3715615. A taped replay of the call will be available beginning at
approximately 12:00 p.m. (EDT)
Wednesday, August 5, until midnight Wednesday, August 12, 2020. To listen to the
replay, dial 877-344-7529, International 412-317-0088, and use
access code 10146229.
About Perrigo Company plc
Perrigo Company plc (NYSE;
TASE: PRGO) is dedicated to making lives better by
bringing Quality, Affordable Self-Care
Products that consumers trust everywhere they are
sold. The Company is a leading provider of over-the-counter
health and wellness solutions that enhance individual well-being by
empowering consumers to proactively prevent or treat conditions
that can be self-managed. Visit Perrigo online
at http://www.perrigo.com.
Forward-Looking Statements
Certain statements in this
press release are "forward-looking statements." These statements
relate to future events or the Company's future financial
performance and involve known and unknown risks, uncertainties and
other factors that may cause the actual results, levels of
activity, performance or achievements of the Company or its
industry to be materially different from those expressed or implied
by any forward-looking statements. In some cases, forward-looking
statements can be identified by terminology such as "may," "will,"
"could," "would," "should," "expect," "forecast," "plan,"
"anticipate," "intend," "believe," "estimate," "predict,"
"potential" or the negative of those terms or other comparable
terminology. The Company has based these forward-looking statements
on its current expectations, assumptions, estimates and
projections. While the Company believes these expectations,
assumptions, estimates and projections are reasonable, such
forward-looking statements are only predictions and involve known
and unknown risks and uncertainties, many of which are beyond the
Company's control, including: the effect of the novel coronavirus
(COVID-19) pandemic and the associated economic downturn and supply
chain impacts on the Company's business; general economic, credit,
and market conditions; future impairment charges; customer
acceptance of new products; competition from other industry
participants, some of whom have greater marketing resources or
larger market shares in certain product categories than the Company
does; pricing pressures from customers and consumers; resolution of
uncertain tax positions, including the Company's appeal of the
Notice of Assessment (the "NoA") issued by the Irish tax authority
and the draft and final Notices of Proposed Assessment ("NOPAs")
issued by the U.S. Internal Revenue Service and the impact that an
adverse result in any such proceedings would have on operating
results, cash flows, and liquidity; pending and potential
third-party claims and litigation, including litigation relating to
the Company's restatement of previously-filed financial information
and litigation relating to uncertain tax positions, including the
NoA and the NOPAs; potential impacts of ongoing or future
government investigations and regulatory initiatives; potential
costs and reputational impact of product recalls or sales halts;
the impact of tax reform legislation and healthcare policy; the
timing, amount and cost of any share repurchases; fluctuations in
currency exchange rates and interest rates; the consummation of
announced acquisitions or dispositions and the success of such
transactions, and the Company's ability to realize the desired
benefits thereof; and the Company's ability to execute and achieve
the desired benefits of announced cost-reduction efforts and
strategic and other initiatives. An adverse result with
respect to our appeal of any material outstanding tax assessments
or pending litigation, including securities or drug pricing
matters, could ultimately require the use of corporate assets to
pay such assessments, damages from third-party claims, and related
interest and/or penalties, and any such use of corporate assets
would limit the assets available for other corporate purposes.
Statements regarding the separation of the Rx business, including
the expected benefits, anticipated timing, form of any such
separation and whether the separation ultimately occurs, are all
subject to various risks and uncertainties, including future
financial and operating results, our ability to separate the
business, the effect of existing interdependencies with our
manufacturing and shared service operations, and the tax
consequences of the planned separation to the Company or its
shareholders. These and other important factors, including those
discussed under "Risk Factors" in the Company's Form 10-K for the
year ended December 31, 2019, as well as the Company's
subsequent filings with the United States Securities and Exchange
Commission, may cause actual results, performance or achievements
to differ materially from those expressed or implied by these
forward-looking statements. The forward-looking statements in this
press release are made only as of the date hereof, and unless
otherwise required by applicable securities laws, the Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/perrigo-to-release-second-quarter-2020-financial-results-on-august-5-2020-301093913.html
SOURCE Perrigo Company plc